The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 ISTA Pharmaceuticals Inc.  (ISTA) Trade Now »     Rate ISTA  -  Discuss ISTA  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate ISTA:



ISTA Analysis & Videos »


ISTA: Bull or Bear?

Target Price Raised Graphic_rating_buy ISTA
Extreme_mouse_sports_
N/A
 -8.57%
in 7 days

 

06/29/09 - RBC Capital Markets

<> <> NEW YORK, June 29 (newratings.com) - Analysts at RBC Capital Markets maintain their "sector perform" rating on ISTA Pharmaceuticals (ISTA) . The target price has been raised from $3 to $5.

In a research note published this morning, the analysts mention that an FDA panel has voted 7-0 in favour of approving Bepreve. The FDA approval reduces some risk related to the approval of Bepreve, the analysts say. ISTA Pharmaceuticals is likely to launch the drug by in January 2010, RBC Capital Markets adds. The company’s share price has, ho...
By  Corey Murphy   (-2.57%  risk: conservative)  06/29/09 Comment


FDA Extreme Trades: 16 Stocks Under $5 Graphic_rating_buy ISTA
Mikerun
73%
 -11.30%
in 9 days
<> Below are FDA extreme trades among 16 companies with stock prices under $5 from the <font> BioMedReports.com FDA Calendar </font> (database includes 225 entries as of 6/27/09) which have pending FDA decisions for either new drug products, biological agents, medical devices, or diagnostic tests that may have a major impact on each of the underlying stock prices. A high risk/reward trading approach to consider for speculative traders is investing a small amount of money that you can afford to lose in a basket of stocks included in <> <font> Extreme FDA and Clinical Trial Calendar Trade...
By  Mike Havrilla   (+1.04%  risk: conservative)  06/27/09 Comment


Bullish on ISTA ... Graphic_rating_buy ISTA
450vampyr_avatar-med
N/A
 +85.71%
in 57 days
ISTA Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, discovers, develops, and markets therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye in the United States. The company offers Xibrom for the treatment of inflammation and pain following cataract surgery; Istalol for the treatment of glaucoma; and Vitrase for use as a spreading agent. Its developing products include Bepotastine ophthalmic solution for allergic conjunctivitis; T-Pred, a Phase III clinical trial product candidate for the treatment of steroid-responsive inflammatory ocular conditions; Ecabet S...
By  supratrader   (+2.48%  risk: conservative)  05/10/09 Comment


Get free stock alert for ISTA:
Your Email Address:





People Bullish on ISTA

Extreme_mouse_sports_
Corey Murphy
Analyst
N/A
6 days ago

Mikerun
Mike Havrilla
Principal
73%
8 days ago

450vampyr_avatar-med
supratrader
Principal
N/A
about 1 mo ago


People Bearish on ISTA

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +42.40% 271
2 Gerald Greene 18.14 +59.31% 139
3 stockmarketfunding.com 17.66 +22.00% 34
4 akiralegrand 13.47 +15.91% 48
5 anup2104 12.13 +37.83% 12


POPULAR STOCKS
Symbol Company Name Sentiment
ETFC E*Trade Financial Corp
GOOG Google Inc
BIDU Baiducom Inc ADS
FRE Freddie Mac
RIO Companhia Vale Do Rio Doce
GM General Motors Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on ISTA


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About ISTA Pharmaceuticals Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch